Could cause temporary or reversible harm; serious harm is unlikely.
Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.
| Brand name | LISINOPRIL |
| Generic name | LISINOPRIL |
| Active ingredient(s) | LISINOPRIL |
| Distributed by / for | Lupin Pharmaceuticals Inc., Baltimore, MD 21202 |
| NDC | 68180-513-03 |
| Full product label | Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03. |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Nationwide within the US. |
| Quantity | 4,224 bottles |
| Recall initiated | 2020-05-28 |
| Report date | 2020-06-17 |
| Recall completed | 2021-05-04 |
| Recall number | D-1290-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗